Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/25/2025
-
MarketBeat
6/5/2026
-
Seeking Alpha: Transcripts
6/5/2026
-
SeekingAlpha
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
6/5/2026
-
SeekingAlpha
Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA)
6/3/2026
-
TipRanks Financial Blog
6/3/2026
-
TipRanks Financial Blog
6/3/2026
-
SeekingAlpha
6/3/2026
-
Globe Newswire
6/2/2026
-
Globe Newswire
5/29/2026
-
TipRanks Financial Blog
5/29/2026
-
Globe Newswire
5/19/2026
-
TipRanks Financial Blog
5/18/2026
-
TipRanks Financial Blog
5/18/2026
-
TipRanks Financial Blog
5/17/2026
-
SeekingAlpha
5/15/2026
-
Seeking Alpha: Transcripts
5/15/2026
-
SeekingAlpha
5/15/2026
-
TipRanks Financial Blog
5/15/2026
-
TipRanks Financial Blog
5/15/2026
-
Globe Newswire
5/11/2026
-
Finbold Stock News
5/11/2026
-
Simply Wall St
5/10/2026
-
Simply Wall St
5/10/2026
-
TipRanks Financial Blog
5/9/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 6, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 825 6990
Address
171 Oyster Point Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201...
more